Press Releases from Exactitude Consultancy (19422 total)
Neurofibroma Market to Reach USD 1.1 Billion by 2034
The global Neurofibroma Market is experiencing steady momentum, driven by increasing prevalence of neurofibromatosis, advancements in molecular diagnostics, and rising research funding for rare genetic…
Molybdenum Cofactor Deficiency Type A (MoCD-A) Market New Product Development & …
Introduction
Molybdenum Cofactor Deficiency Type A (MoCD-A) is a rare, life-threatening metabolic disorder that presents significant clinical challenges due to its early onset, rapid progression, and…
Mucopolysaccharidosis I (MPS I) Market Emerging Trends and Growth Prospects 2034
Introduction
Mucopolysaccharidosis I (MPS I) is a rare lysosomal storage disorder caused by the deficiency of the enzyme α-L-iduronidase, leading to progressive multisystemic complications including skeletal…
Pachyonychia Congenita Market to Reach USD 750 Million by 2034
The Pachyonychia Congenita (PC) Market represents a highly specialized niche within the rare genetic disorders segment. Characterized by painful thickened nails, oral leukokeratosis, plantar keratoderma,…
Myotonic Dystrophy Market Detailed Industry Report Analysis 2025-2034
Introduction
Myotonic dystrophy (DM) is one of the most common forms of adult-onset muscular dystrophy, characterized by progressive muscle weakness, myotonia, cardiac issues, respiratory complications, and…
Neurofibromatosis Type 2 (NF2) Market Massive Growth opportunity Ahead
Introduction
Neurofibromatosis Type 2 (NF2) is a rare genetic disorder caused by mutations in the NF2 gene, leading to the development of benign tumours on the…
Sanfilippo Syndrome Market to Reach USD 3 Billion by 2034
The Sanfilippo Syndrome Market is entering a phase of growing attention from both the healthcare industry and patient advocacy groups. Sanfilippo syndrome (also known as…
PCSK9 Inhibitors Market Growth, Applications, Innovations and Business Outlook b …
Introduction
Cardiovascular diseases remain the leading cause of mortality worldwide, with elevated low-density lipoprotein cholesterol (LDL-C) being one of the most significant risk factors. While statins…
Thalassemia Market to Reach USD 9.1 Billion by 2034
The Thalassemia Market is entering a critical phase of expansion as healthcare systems worldwide focus on rare genetic blood disorders. Thalassemia, an inherited hemoglobin disorder,…
Progressive Familial Intrahepatic Cholestasis (PFIC) Market Growth, Trends, Cons …
Introduction
Progressive Familial Intrahepatic Cholestasis (PFIC) is a group of rare, inherited liver disorders characterized by defective bile secretion, leading to chronic cholestasis, liver damage, and…
Proteus Syndrome Market Set to Witness Significant Growth by 2025-2034
Introduction
Proteus syndrome is an extremely rare, progressive genetic disorder caused by mosaic mutations in the AKT1 gene, leading to asymmetric overgrowth of bones, skin, blood…
Vascular Ehlers-Danlos Syndrome (vEDS) Market to Reach USd 2.8 Billion by 2034
The Vascular Ehlers-Danlos Syndrome (vEDS) Market is evolving as healthcare systems place greater emphasis on rare connective tissue disorders. vEDS is the most severe subtype…
Rett Syndrome Market 2025-2034 Business Outlook, Critical Insight and Growth
Introduction
Rett syndrome is a rare, progressive neurodevelopmental disorder that almost exclusively affects girls, with an incidence of roughly 1 in 10,000 to 15,000 live female…
Usher Syndrome Market Insights and Future Outlook
Introduction
Usher syndrome is a rare genetic disorder and the leading cause of combined deafness and blindness worldwide. It is caused by mutations in genes responsible…
Von Willebrand Disease (VWD) Market Growth, Trends, Consumer Demand and Key Oppo …
Introduction
Von Willebrand Disease (VWD) is the most common inherited bleeding disorder, affecting both men and women across all age groups. The disease results from either…
Alpha-1 Antitrypsin Deficiency (AATD) Market Set to Witness Significant Growth b …
Introduction
Alpha-1 Antitrypsin Deficiency (AATD) is a rare genetic disorder caused by mutations in the SERPINA1 gene, leading to low levels or dysfunction of the alpha-1…
AL Amyloidosis Market 2025-2034 Business Outlook, Critical Insight and Growth
Introduction
AL Amyloidosis, also known as primary systemic amyloidosis, is a rare and life-threatening disorder caused by the misfolding of immunoglobulin light chains produced by plasma…
Argininosuccinic Aciduria (ASA) Market Insights and Future Outlook
Introduction
Argininosuccinic aciduria (ASA) is a rare urea cycle disorder caused by mutations in the ASL (argininosuccinate lyase) gene, which impairs the body's ability to break…
Cone-Rod Dystrophies (CRDs) Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Cone-rod dystrophies (CRDs) are a rare group of inherited retinal disorders marked by the progressive loss of cone photoreceptors (responsible for color and central vision)…
Netherton Syndrome Market is expected to reach USD 2.5 billion by 2034
Netherton Syndrome is a rare, inherited autosomal recessive skin disorder caused by mutations in the SPINK5 gene, which encodes the serine protease inhibitor LEKTI. The…
DDR-Defective Tumors Market New Product Development & Latest Trends
Introduction
DNA Damage Response (DDR) pathways are critical for maintaining genome integrity. When these pathways are defective, mutations accumulate, leading to tumor development. DDR-defective tumors are…
Lipodystrophy Syndrome (LS) Market to Reach USD 2.5 Billion by 2034
Lipodystrophy Syndromes (LS) are a group of rare disorders characterized by the selective loss or redistribution of adipose tissue, often leading to severe metabolic complications…
Hutchinson-Gilford Progeria Syndrome (HGPS) market is expected to reach USD 1.1 …
Hutchinson-Gilford Progeria Syndrome (HGPS), commonly known as progeria, is an ultra-rare genetic disorder caused by a mutation in the LMNA gene. This mutation leads to…
Familial Adenomatous Polyposis (FAP) market is expected to reach USD 2.5 billion …
Familial Adenomatous Polyposis (FAP) is a rare inherited disorder caused by mutations in the APC gene, leading to the development of hundreds to thousands of…
Eisenmenger Complex Market Emerging Trends and Growth Prospects 2034
Eisenmenger complex is a rare and severe complication of congenital heart disease, typically arising from untreated ventricular septal defects (VSDs), atrial septal defects (ASDs), or…
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Market Detailed Ind …
Introduction
Familial hypercholesterolemia (FH), also referred to as Type II hyperlipoproteinemia, is a genetic disorder of lipid metabolism characterized by very high levels of low-density lipoprotein…
Edward's Syndrome (Trisomy 18) Market to Reach USD 2.9 Billion by 2034
Edward's Syndrome, also known as Trisomy 18, is a rare chromosomal disorder caused by the presence of an extra copy of chromosome 18. It affects…
Cystinuria Market to Reach USD 2.5 Billion by 2034
Cystinuria is a rare inherited metabolic disorder characterized by defective renal transport of certain amino acids, particularly cystine, which leads to the formation of recurrent…
Cerebrotendinous Xanthomatosis (CTX) market is expected to reach USD 650 million …
Cerebrotendinous Xanthomatosis (CTX) is an ultra-rare autosomal recessive metabolic disorder caused by mutations in the CYP27A1 gene, leading to defective bile acid synthesis. The condition…
Angioedema Market to Reach USD 7.9 Billion by 2034
Angioedema is a condition characterized by sudden swelling in the deeper layers of the skin, often affecting the face, lips, tongue, throat, and extremities. It…
Idiopathic CD4 Lymphocytopenia (ICL) Market Detailed Industry Report Analysis 20 …
Introduction
Idiopathic CD4 lymphocytopenia (ICL) is a rare, acquired immune disorder characterized by persistently low CD4+ T-cell counts without evidence of HIV infection or other known…
Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Market to Reach …
Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID), also known as "bubble boy disease," is an ultra-rare genetic disorder caused by mutations in the ADA gene, leading…
Laband Syndrome Market Detailed Industry Report Analysis 2025-2034
Introduction
Laband syndrome, also known as Zimmermann-Laband syndrome (ZLS), is an ultra-rare genetic disorder characterized by gingival fibromatosis (severe gum overgrowth), distinctive craniofacial features, hypertrichosis, hepatosplenomegaly,…
Wilson Disease Market is expected to reach USD 4.6 billion by 2034
Wilson Disease is a rare autosomal recessive genetic disorder caused by mutations in the ATP7B gene, leading to impaired copper metabolism. Excessive copper accumulation in…
Von Hippel-Lindau (VHL) Disease Market to Reach USD 7.8 Billion by 2034
Von Hippel-Lindau (VHL) disease is a rare inherited disorder caused by mutations in the VHL tumor suppressor gene, leading to the development of benign and…
Infantile Neuroaxonal Dystrophy (INAD) market is expected to reach USD 1.1 billi …
Infantile Neuroaxonal Dystrophy (INAD) is a devastating ultra-rare neurodegenerative disorder, typically presenting between 6 months and 3 years of age. It is most commonly associated…
Niemann-Pick Disease Type A (NPD-A) Market is expected to reach USD 3.5 billion …
Niemann-Pick Disease Type A (NPD-A) is a rare, inherited lysosomal storage disorder caused by mutations in the SMPD1 gene, resulting in deficient activity of acid…
Stargardt Disease Market is expected to reach USD 3.5 billion by 2034
Stargardt disease, the most common form of inherited juvenile macular degeneration, is caused by mutations in the ABCA4 gene. It typically manifests in late childhood…
Pseudoxanthoma Elasticum (PXE) market is expected to reach USD 2.6 billion by 20 …
Pseudoxanthoma Elasticum (PXE) is a rare genetic disorder caused by mutations in the ABCC6 gene, leading to progressive mineralization of connective tissues. PXE primarily affects…
Propionic Acidemia (PA) market is expected to reach USD 2.3 billion by 2034
Propionic Acidemia (PA) is a rare autosomal recessive metabolic disorder caused by mutations in the PCCA or PCCB genes, leading to deficiency of the mitochondrial…
Prader-Willi Syndrome (PWS) market is expected to reach USD 3.1 billion by 2034
Prader-Willi Syndrome (PWS) is a complex, rare genetic disorder caused by the loss of function of specific genes on chromosome 15. It is characterized by…
Niemann-Pick Disease Type C (NPC) Market is expected to reach USD 2.8 billion by …
Niemann-Pick Disease Type C (NPC) is a rare, progressive, and life-threatening lysosomal storage disorder caused by mutations in the NPC1 or NPC2 genes. The disease…
Neurofibromatosis Type 1 (NF1) Market to Reach USD 2.5 Billion by 2034
Neurofibromatosis Type 1 (NF1) is one of the most common genetic disorders among rare diseases, affecting approximately 1 in 3,000 individuals worldwide. It is caused…
Mucopolysaccharidosis II (Hunter Syndrome) market is expected to reach USD 2.8 b …
Mucopolysaccharidosis II (MPS II), commonly known as Hunter Syndrome, is a rare X-linked lysosomal storage disorder caused by a deficiency of the enzyme iduronate-2-sulfatase. The…
Morquio Syndrome Market is expected to reach USD 3 billion by 2034
Morquio Syndrome, also known as Mucopolysaccharidosis Type IV (MPS IV), is a rare inherited lysosomal storage disorder characterized by the body's inability to break down…
Limb-Girdle Muscular Dystrophy (LGMD) Market to Hit USD 3.5 Billion by 2034
Limb-Girdle Muscular Dystrophy (LGMD) represents a heterogeneous group of inherited neuromuscular disorders characterized by progressive weakness in the shoulder and hip muscles. Affecting approximately 1…
Hereditary Angioedema (HAE) market is expected to reach USD 4.2 billion by 2034
Hereditary Angioedema (HAE) is a rare, potentially life-threatening genetic disorder characterized by recurrent swelling episodes in the skin, gastrointestinal tract, and airways. Caused by C1…
Fragile X Syndrome (FXS) Market is expected to reach USD 2.5 billion by 2034
Fragile X Syndrome (FXS) is the most common inherited cause of intellectual disability and a leading genetic contributor to autism spectrum disorders. Caused by a…
Duchenne Muscular Dystrophy (DMD) market is expected to reach USD 5.6 billion by …
Duchenne Muscular Dystrophy (DMD) is one of the most severe genetic neuromuscular disorders, primarily affecting boys, caused by mutations in the dystrophin gene. With progressive…
Huntington's Disease Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Huntington's Disease (HD) is a devastating rare, inherited neurodegenerative disorder that progressively impairs movement, cognition, and behavior. Affecting approximately 3 to 7 individuals per 100,000…
Go To Page: 21 22 23 24 25 26 27 28 29 30 231 232 233 234 235 236 237 238 239 240
